Baird Financial Group’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$577K Buy
10,431
+1,485
+17% +$70.7K ﹤0.01% 1430
2025
Q4
$334K Buy
+8,946
New +$363K ﹤0.01% 1604
2019
Q4
Sell
-138,421
Closed -$2.95M 1540
2019
Q3
$2.95M Buy
138,421
+22,650
+20% +$620K 0.01% 662
2019
Q2
$3.68M Buy
115,771
+91,115
+370% +$2.86M 0.01% 606
2019
Q1
$814K Buy
+24,656
New +$767K ﹤0.01% 919

Other funds holding PAHC

Baird Financial Group's PAHC Position: Q1 2026 in Review

Baird Financial Group increased its Phibro Animal Health (PAHC) stake by 17% in Q1 2026, buying an estimated $70.7K and bringing the position to 10,431 shares worth $577K. The position accounts for ﹤0.01% of the portfolio, ranked #1430.

Baird Financial Group first reported a position in PAHC in Q1 2019 and has held it in 5 quarters since. The position peaked at $3.68M in Q2 2019. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Baird Financial Group held 10,431 shares of Phibro Animal Health worth $577K as of Q1 2026.
  • Baird Financial Group bought 1,485 Phibro Animal Health shares in Q1 2026, an estimated $70.7K.
  • Phibro Animal Health made up ﹤0.01% of Baird Financial Group's portfolio in Q1 2026, its #1430 holding.
  • Baird Financial Group first reported a position in Phibro Animal Health in Q1 2019 and has held it in 5 quarters since.
  • Baird Financial Group's Phibro Animal Health position peaked at $3.68M in Q2 2019.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.